Cystic Fibrosis Trial, Recruiting NCT01851642 Sponsor: University of Florida Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT01851642
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have signed a consent form agreeing to take part in the study
  • If you are a woman who could become pregnant, you have tested negative for pregnancy
  • Your hemoglobin (a measure of healthy red blood cells) is above 12.5 g/dl on the day you take part
  • You have tested negative for nicotine in a urine test

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You weigh less than 50 kg (about 110 pounds)
  • You have had anemia (low red blood cells) that required blood transfusions, special injections, or iron supplements in the past 36 months (3 years)
  • Your hemoglobin was found to be low (below 12.5 g/dl) at any point in the past 90 days
  • Your blood pressure is too high (top number above 180 or bottom number above 100)
  • Your veins are difficult to access for blood draws
  • You have donated a large amount of blood (more than 200 ml or 7 ounces, such as a standard blood bank donation) in the past 56 days
  • You have a significant heart, bleeding, or neurological condition, or any other serious medical condition that the study doctor feels could affect your safety (confirm with trial site)
  • You have a psychiatric or cognitive (thinking/memory) condition that could affect your safety during the trial
  • You are a current smoker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Karina Serban, MD, University of Florida, College of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine

Phone: 352-273-8666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 August 2007
Est. completion
20 July 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluation of macrophage function.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov